96 related articles for article (PubMed ID: 10865444)
1. Natural inhibitors of tumour necrosis factor-alpha production, secretion and function.
Habtemariam S
Planta Med; 2000 May; 66(4):303-13. PubMed ID: 10865444
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for modulating TNF alpha in immune and inflammatory disease.
Baugh JA; Bucala R
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458
[TBL] [Abstract][Full Text] [Related]
3. [Cytokines and antagonists in septic shock].
Girardin E; Dayer JM
Schweiz Med Wochenschr; 1993 Mar; 123(11):480-91. PubMed ID: 8386392
[TBL] [Abstract][Full Text] [Related]
4. Modulating TNF-alpha signaling with natural products.
Paul AT; Gohil VM; Bhutani KK
Drug Discov Today; 2006 Aug; 11(15-16):725-32. PubMed ID: 16846800
[TBL] [Abstract][Full Text] [Related]
5. Anti-TNF-alpha therapies: the next generation.
Palladino MA; Bahjat FR; Theodorakis EA; Moldawer LL
Nat Rev Drug Discov; 2003 Sep; 2(9):736-46. PubMed ID: 12951580
[TBL] [Abstract][Full Text] [Related]
6. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
Fenner H
Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
[TBL] [Abstract][Full Text] [Related]
7. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
8. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
Meyer O
Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor as a pharmacological target.
Ghezzi P; Cerami A
Methods Mol Med; 2004; 98():1-8. PubMed ID: 15064428
[TBL] [Abstract][Full Text] [Related]
10. TNF alpha as a therapeutic target in rheumatoid arthritis.
Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN
Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-alpha gene expression and production in human umbilical arterial endothelial cells.
Neuhaus T; Totzke G; Gruenewald E; Juesten HP; Sachinidis A; Vetter H; Ko Y
Clin Sci (Lond); 2000 Apr; 98(4):461-70. PubMed ID: 10731482
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of TNF-alpha production, NK cell activity and IL-12 p35 mRNA expression by methionine enkephalin.
Zhong F; Li XY; Yang SL
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):182-5. PubMed ID: 9772675
[TBL] [Abstract][Full Text] [Related]
14. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
15. TNF-mediated inflammatory disease.
Bradley JR
J Pathol; 2008 Jan; 214(2):149-60. PubMed ID: 18161752
[TBL] [Abstract][Full Text] [Related]
16. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
[TBL] [Abstract][Full Text] [Related]
17. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
Browne WL; Wilson WR; Baguley BC; Ching LM
Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501
[TBL] [Abstract][Full Text] [Related]
18. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA
Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166
[TBL] [Abstract][Full Text] [Related]
19. Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-alpha and nitric oxide production in vivo and in vitro.
Haskó G; Szabó C; Németh ZH; Lendvai B; Vizi ES
Br J Pharmacol; 1998 Jul; 124(6):1099-106. PubMed ID: 9720779
[TBL] [Abstract][Full Text] [Related]
20. Cytokines as mediators of graft-versus-host disease.
Cohen J
Bone Marrow Transplant; 1988 May; 3(3):193-7. PubMed ID: 3048486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
